M. Kano: Department of Neurophysiology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
J Physiol. 2013 Oct 1;591(19):4765-76. doi: 10.1113/jphysiol.2013.254474. Epub 2013 Jul 15.
The endocannabinoid (eCB) 2-arachidonoylglycerol (2-AG) produced by diacylglycerol lipase α (DGLα) is one of the best-characterized retrograde messengers at central synapses. It has been thought that 2-AG is produced 'on demand' upon activation of postsynaptic neurons. However, recent studies propose that 2-AG is pre-synthesized by DGLα and stored in neurons, and that 2-AG is released from such 'pre-formed pools' without the participation of DGLα. To address whether the 2-AG source for retrograde signalling is the on-demand biosynthesis by DGLα or the mobilization from pre-formed pools, we examined the effects of acute pharmacological inhibition of DGL by a novel potent DGL inhibitor, OMDM-188, on retrograde eCB signalling triggered by Ca(2+) elevation, Gq/11 protein-coupled receptor activation or synergy of these two stimuli in postsynaptic neurons. We found that pretreatment for 1 h with OMDM-188 effectively blocked depolarization-induced suppression of inhibition (DSI), a purely Ca(2+)-dependent form of eCB signalling, in slices from the hippocampus, striatum and cerebellum. We also found that at parallel fibre-Purkinje cell synapses in the cerebellum OMDM-188 abolished synaptically induced retrograde eCB signalling, which is known to be caused by the synergy of postsynaptic Ca(2+) elevation and group I metabotropic glutamate receptor (I-mGluR) activation. Moreover, brief OMDM-188 treatments for several minutes were sufficient to suppress both DSI and the I-mGluR-induced retrograde eCB signalling in cultured hippocampal neurons. These results are consistent with the hypothesis that 2-AG for synaptic retrograde signalling is supplied as a result of on-demand biosynthesis by DGLα rather than mobilization from presumptive pre-formed pools.
内源性大麻素(eCB)2-花生四烯酰甘油(2-AG)由二酰基甘油脂肪酶α(DGLα)产生,是中枢突触中研究最为透彻的逆行信使之一。人们认为,2-AG 是在突触后神经元激活时“按需”产生的。然而,最近的研究提出,2-AG 是由 DGLα预先合成并储存在神经元中,并且 2-AG 是从这种“预先形成的池”中释放出来的,而不需要 DGLα 的参与。为了解决逆行信号转导的 2-AG 来源是 DGLα 的按需生物合成还是来自预先形成的池的动员,我们研究了新型强效 DGL 抑制剂 OMDM-188 对 Ca(2+)升高、Gq/11 蛋白偶联受体激活或这两种刺激在突触后神经元中协同作用触发的逆行 eCB 信号转导的影响。我们发现,在海马体、纹状体和小脑切片中,1 h 的 OMDM-188 预处理可有效阻断去极化诱导的抑制抑制(DSI),这是一种纯 Ca(2+)-依赖性的 eCB 信号转导形式。我们还发现,在小脑的平行纤维-浦肯野细胞突触中,OMDM-188 消除了已知由突触后 Ca(2+)升高和 I 型代谢型谷氨酸受体(I-mGluR)激活协同作用引起的突触后逆行 eCB 信号转导。此外,对培养的海马神经元进行几分钟的短暂 OMDM-188 处理足以抑制 DSI 和 I-mGluR 诱导的逆行 eCB 信号转导。这些结果与 2-AG 用于突触逆行信号转导的假设一致,即 2-AG 是通过 DGLα 的按需生物合成而不是从假定的预先形成的池动员提供的。